About GeneDx Holdings Corp.
GeneDx Holdings leads in exome and genome sequencing for rare disease diagnosis. High-growth genomics company, no dividend, elevated beta. Rich CSP premiums but sentiment-driven swings around earnings, reimbursement policy, and competitive genomics developments add meaningful gap risk.
Diagnostics & Research